Labco conducts clinical tests and delivers results to prescribing doctors and patients, while offering assistance with the interpretation of clinical results through in-house laboratory doctors. The company operates in European nations such as France, Spain, Italy, Portugal, Belgium and the UK. It has more than 160 routine and specialist laboratories and 1,000 collection centres across Europe. Also, it has one of the largest portfolios of hospital outsourcing contracts in Europe, providing services to both ambulatory care and hospitals. “Labco has generated significant growth across Europe, so it makes huge sense for us to partner with a private equity sponsor with a strong European presence, a proven track record in the healthcare sector, including diagnostics and the ability to help us expand our operations and services across Europe and internationally both organically and through acquisitions,” said Philippe Charrier, CEO, Labco. Employing around 6,000 employees and medical personnel, Labco reported pro forma revenues of €650 million in 2014. “Labco is a high-quality business in the European clinical diagnostics sector. This sector is growing strongly as a result of ageing populations, an increasing focus on the early detection and prevention of illnesses and the opportunities for healthcare cost savings”, said Alex Leslie, Senior Principal, Cinven.